Hysteroscopy Procedures Market Current and Future Demand, Analysis, Growth and Forecast By 2032

 The Hysteroscopy Procedures Market was estimated at US$ 3.7 Billion in 2021 and is anticipated to grow at a CAGR of 8.4% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 9.0 Billion.



The value of hospitals increased at a CAGR of roughly 8.2% between 2017 and 2021 due to a higher volume of patients for gynecological operations than other healthcare facilities. Any crisis that may emerge during or after medical treatments can be handled by the hospitals. Furthermore, hospitals offer a wide range of treatments, which will help the business thrive in the forthcoming years.

Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15807

According to the National Library of Medicine, about 30 thousand myomectomies for fibroids are performed in the United States each year. Furthermore, since hospitals provide primary healthcare in the majority of countries, the number of hysteroscopy procedures conducted in hospitals is larger than in other healthcare institutions. The primary revenue drivers influencing the Hysteroscopy Procedures Market include the rising prevalence of gynecological illnesses such as ovarian cancer, uterine fibroids, and ovarian cysts, as well as the global trend toward minimally invasive surgery.

Ovarian cysts are highly frequent in females; wherein around 7% of women globally are reported to have ovarian cysts. In the United States, there are 15 cases per 100 thousand women per year. Women ovarian cysts are seen in 18% of postmenopausal women and are prevalent in all premenopausal women. The usage of hysteroscopy procedures in hospitals, clinics, and ambulatory surgical centres is increasing due to a growth in the number of gynecological illnesses.

Minimally invasive surgery is a medical procedure that involves the use of a hysteroscope, which is a thin, lighted tube that is inserted into the uterus through the cervix.

Competitive Landscape

  • Medtronic
  • Stryker Corporation
  • Hologic Inc.
  • KARL STORZ SE & Co. KG
  • Medical devises Business Services Inc.
  • Olympus Corporation
  • Delmont Imaging
  • CooperCompanies
  • Richard Wolf GmbH
  • B. Braun Melsungen AG
  • Maxer Endoscopy GmbH
  • Boston Scientific Corp.
  • MedGyn Products, Inc.
  • Meditrina, Inc. (Aveta)
  • Lina Medical APS
  • Luminelle

Some of the recent developments of key Hysteroscopy Procedures market providers are as follows:

  • In May 2020, Olympus Corporation signed an agreement with UVision 360 to market its LUMINELLE DTx hysteroscopy equipment in the United States with an objective to strengthen and continue growth in United States hysteroscopy procedure market.
  • In November 2019, the AvetaTM Hysteroscopy System has been introduced by Meditrina, Inc. during American Association of Gynecologic Laparoscopists convention. The launch of new product will help Meditirna, Inc to strengthen its position in the market and expand its hysteroscopy procedure product portfolio.
  • In January 2019, Hologic Inc. launched the Omni hysteroscope in the United States, a three-in-one modular scope with superior imaging capabilities suited for both diagnostic and therapeutic hysteroscopic end uses.

To learn more about this report @ https://www.futuremarketinsights.com/reports/hypsteroscopy-procedures-market

Hysteroscopy Procedures Market Segmentation

By End Use:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more